Schedule 13G ownership disclosure

KYNTRA BIO INC

Common Stock · CUSIP: 31572Q881

Event date: 2025-06-30

Filing-level shares
178,040
Percent of class
4.40%
  • The Vanguard Group

    Shares: 178,040 · Class: 4.40%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000725
Form type
SCHEDULE 13G/A
Filer
KYNTRA BIO, INC.
CIK
CIK 921299
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub